| Code | 3921B | ||||||||||
| MA number | 27/0157/15-S | ||||||||||
| Product Form: | tbl flm 175x150 mg/37,5 mg/200 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.04.2015 |
| SPC: |
SPC_TADOGLEN_01.2020.docx
|
| PIL: |
PIL_TADOGLEN_01.2020.doc
|
| Safety feature | Yes |
| Data update: | 30.09.2021 |
